Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual MeetingGlobeNewsWire • 02/22/22
Athira Pharma Announces Appointment of Grant Pickering to its Board of DirectorsGlobeNewsWire • 01/31/22
Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy BodiesGlobeNewsWire • 01/25/22
Is the Options Market Predicting a Spike in Athira Pharma (ATHA) Stock?Zacks Investment Research • 12/13/21
Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer's Disease at CTAD ConferenceGlobeNewsWire • 11/10/21
Athira Pharma to Host Educational Webinar on the Clinical Applications of ERP P300GlobeNewsWire • 10/29/21
Athira Pharma Announces Completion of Enrollment in Phase 2 ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer's DiseaseGlobeNewsWire • 10/22/21
Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigationGeekWire • 10/21/21
Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer's Disease (CTAD) ConferenceGlobeNewsWire • 09/29/21
Athira Pharma, Inc. (ATHA) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 09/17/21
Last Day for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLCBusiness Wire • 08/24/21
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/24/21
ATHA DEADLINE TODAY: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Now, Lead Plaintiff Deadline TodayNewsfile Corp • 08/24/21
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Athira Pharma, Inc. Investors – ATHABusiness Wire • 08/23/21
CLASS ACTION UPDATE for ATHA, CRMD and VIEW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 08/23/21
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/23/21
Athira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer's Disease SummitGlobeNewsWire • 08/23/21
FINAL DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHANewsfile Corp • 08/23/21
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)Business Wire • 08/23/21
FINAL NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHAPRNewsWire • 08/21/21
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) InvestorsPRNewsWire • 08/20/21